Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)
Status:
COMPLETED
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
This will be a prospective, double-blind randomized controlled clinical trial. There will be two arms of treatment: intervention and control group. Preoperatively patients will be allocated at random to receive ultrasound guided bilateral ESP block either with the local anesthetic (intervention group) normal saline (control group). The aim of this study is to examine the effect of ESP block to increase the Quality of Recovery (measured via QoR-15 total score) and decrease opioid consumption.
Phase:
NA
Details
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital